Mirae Asset Healthcare Fund Direct Growth
Equity
Direct
Sector - Healthcare
About the Fund
Mirae Asset Healthcare Fund Direct Growth is an equity fund. This fund was started on 2 June, 2018. The fund is managed by Vrijesh Kasera. The fund could potentially beat inflation in the long-run.
Key Parameters
- Mirae Asset Healthcare Fund Direct Growth has ₹2312 Cr worth of assets under management (AUM) as on Jun 2024 and is more than category average.
- The fund has an expense ratio 0.5.
Returns
Mirae Asset Healthcare Fund Direct Growth has given a CAGR return of 24.40% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 45.98%, 16.14% and 30.69% respectively.
Holdings
Mirae Asset Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Financial Services, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Dr Reddy's Laboratories Ltd, Apollo Hospitals Enterprise Ltd
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of Mirae Asset Healthcare Fund Direct Growth
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. Mirae Asset Healthcare Fund Direct Growth has no lock in period.
Fund Performance
2391 people have invested ₹ 1.8Cr in Mirae Asset Healthcare Fund Direct Growth in the last three months
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
5Y returns in the top 25% of the category
Lower expense ratio
Beats FD returns for both 3Y & 5Y duration
No bad points found for this fund.
Fund Overview
| Expense ratio | 0.49% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹2312 Cr |
| Inception Date | 2 June, 2018 |
| Min Lumpsum/SIP | ₹5000/₹500 |
Exit Load | 1% |
| Lock In | No Lock-in |
TurnOver | 14.66% |
| Risk |   Very High Risk |
Fund Distributionas on (30-Jun-24)
Large cap
45.9%
Mid cap
40.5%
Small cap
12%
Sector Allocation
Health
98.7%
Financial Services
1.3%
Basic Materials
0%
All changes are between Apr'24 and Jun'24
as on (30-Jun-24)
See all
Returns for the month of Jun
Top Growth Drivers | 1M Return |
|---|---|
 Dr Reddys Laboratories Ltd | 13.4% |
 Sun Pharmaceuticals Industries Ltd | 7.2% |
 Max Healthcare Institute Ltd | 4.2% |
Vrijesh Kasera
Fund Manager of Mirae Asset Healthcare Fund Direct Growth, since 2 July 2018
Top funds managed
Mutual Fund Insights
In the last 3 years, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 18.75% return, outperforming this fund by 2.61% per annum.
Over the last 1 month, this fund has experienced a 5.0% growth in AUM moving from 2.20K Cr to 2.31K Cr.
Over the last 1 year, this fund has decreased expense ratio by 19.7% moving from 0.61 to 0.49.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 0.49% which is lower than the category average expense ratio of 1.42%.
In the last 1 year, Quant Healthcare Fund Direct Growth has given 60.96% return, outperforming this fund by 14.98%.
In the last 5 years, DSP Healthcare Fund Direct Growth has given 31.51% return, outperforming this fund by 0.82% per annum.
Mirae Asset Healthcare Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 24.4% since inception which is more than its category average return of 23.79%
Fund Allocations
This fund has an allocation of 98.83% in Equity, 0% in Debt and 1.16% in Cash related instruments
AUM size ₹2312 Cr
This fund has AUM of ₹2312 Cr which is more than its category average of ₹ 1743 Cr
Expense Ratio 0.49%
This fund has an expense ratio of 0.49% which is less than its category average expense ratio of 1.44%
Frequently Asked Questions
The current NAV of Mirae Asset Healthcare Fund Direct Growth is ₹38.49 as on 25-Jul-2024.
Existing (Absolute + CAGR) as on 25-Jul-2024.
Mirae Asset Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 7.84% | 7.84% |
6 Month Returns | 17.46% | 17.46% |
1 Year Returns | 45.98% | 45.98% |
3 Years Returns | 56.66% | 16.14% |
5 Years Returns | 281.19% | 30.69% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.49% as on June 2024
₹2312 Cr as on June 2024
Sun Pharmaceuticals Industries Ltd(12.9%), Cipla Ltd(9.49%), Aurobindo Pharma Ltd(9.34%), Dr Reddy's Laboratories Ltd(7.44%), Apollo Hospitals Enterprise Ltd(6.11%) as on June 2024
Health(97.57%), Financial Services(1.26%), Basic Materials(0%) as on June 2024
The alpha ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 0.83 | 1.36 | 4.18 |
As on June 2024
The alpha for Mirae Asset Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 0.9 | 0.94 | 0.95 |
As on June 2024
The Beta for Mirae Asset Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 2.09 | 0.65 | 1.17 |
As on June 2024
The sharpe ratio for Mirae Asset Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Mirae Asset Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Mirae Asset Healthcare Fund Direct Growth | 14.07 | 14.68 | 18.78 |
As on June 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.1 as on June 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.33 as on June 2024. It tells the consistency of the fund in generating superior risk-adjusted performance
Vrijesh Kasera is the fund manager of Mirae Asset Healthcare Fund Direct Growth
The Exit load of Mirae Asset Healthcare Fund Direct Growth is 1%